Skip to content

Ultrasonographic Air Bronchogram in Pediatric CAP

Prognostic Role of Ultrasonographic Air Bronchogram in the Management of Community Acquired Pneumoniae in Children

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03556488
Acronym
USINCHILD
Enrollment
30
Registered
2018-06-14
Start date
2018-05-21
Completion date
2024-04-30
Last updated
2024-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Infectious Disorder, Pneumonia

Keywords

Chest ultrasound, Pediatric community acquired pneumonia, Air bronchogram

Brief summary

This study evaluates the prognostic role of the change of arborescent air bronchogram, a typical ultrasonographic finding of lung consolidation due to pneumonia, in the management of pediatric CAP.

Detailed description

This is a single-center prospective study to evaluate the prognostic role of the change of arborescent air bronchogram, a typical ultrasonographic finding of lung consolidation due to pneumonia, in the management of CAP in terms of: 1) impact on rate of uncomplicated respiratory infections \[rate of uncomplicated CAP\], 2) relationship to the time of resolution of clinical signs \[time to resolution of fever\], 3) change of antibiotic therapy not guided by microbiological examinations and, 4) length of hospitalization. At admission, the Pediatric will evaluate clinical signs of respiratory distress, request microbiologic tests (nasopharyngeal swab specimens and pneumococcal urinary antigen) to detect causative pathogens of CAP, and laboratory tests (complete blood cell count, acute-phase reactants C-reactive protein). Finally, all children will undergo chest radiography (CXR). If CXR should be performed before the admission to Pediatric Unit, the radiological exam will be not repeated. Ultrasonographic evaluation will be performed by Pulmonologists. The first examination will be performed within 12 hours from admission. The Pulmonologists will be blind to clinical and radiological data. In order to characterize the lung consolidation, a grading system based on the presence and the features of air bronchogram \[static, dynamic, dynamic with areas of lung recruitment\] will be adopted. The operator will collect and store images and videos (10seconds), these findings will be reviewed by an expert Clinician in chest US blind to other data. After 48h from the admission, all children will undergo follow-up laboratory tests and lung US. In case of clinical deterioration, children will undergo further ultrasonographic evaluations according pediatric indications. Finally, all children will undergo lung US after 7 ± 2 days from discharge.

Interventions

DIAGNOSTIC_TESTUS air bronchogram score

On ultrasonographic examination, lung consolidation is defined as a subpleural echo-poor region or one with tissue- like echotexture, depending on the extent of air loss and fluid predominance, which is clearly different from the normal pattern. The air bronchogram is characterized as: absent, static, dynamic, dynamic with areas of lung recruitment.

Sponsors

Catholic University of the Sacred Heart
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Suspected CAP * Age from 1 to 16 years old * Admission to Pediatric Unit * Radiographic evidence of lung consolidation * Written informed consent from parents

Exclusion criteria

* Gestational age \< 36 weeks * Previous diagnosis of cystic fibrosis * Congenital pulmonary disease. * Refusal to participate.

Design outcomes

Primary

MeasureTime frameDescription
Rate of uncomplicated CAP48 hoursImpact on rate of uncomplicated respiratory infections
Time to resolution of feverThrough study completion, an average of 7 days.Relationship to the time of resolution of clinical signs
Change of antibiotic therapy48 hoursChange of antibiotic therapy not guided by microbiological examinations
Length of hospitalizationThrough study completion, an average of 10 days.Length of hospitalization

Countries

Italy

Contacts

Primary ContactRiccardo Inchingolo, MD, PhD
riccardo.inchingolo@policlinicogemelli.it+390630154236

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026